diosgenin has been researched along with 9,10-dimethyl-1,2-benzanthracene in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arokia Vijayaanand, M; Kalaimathi, J; Rajalingam, K; Sugunadevi, G; Suresh, K | 1 |
| Rajalingam, K; Sathiyapriya, J; Sivakumar, K; Sugunadevi, G; Suresh, K; Vijayaanand, MA | 1 |
2 other study(ies) available for diosgenin and 9,10-dimethyl-1,2-benzanthracene
| Article | Year |
|---|---|
Anti-tumour and anti-oxidative potential of diosgenin against 7, 12-dimethylbenz(a)anthracene induced experimental oral carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Antioxidants; Carcinogens; Carcinoma, Squamous Cell; Cricetinae; Diosgenin; Lipid Peroxidation; Male; Mesocricetus; Mouth Mucosa; Mouth Neoplasms; Thiobarbituric Acid Reactive Substances | 2012 |
Anticlastogenic effect of diosgenin on 7,12-dimethylbenz(a)anthracene treated experimental animals.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antimutagenic Agents; Bone Marrow Cells; Chromosome Aberrations; Cricetinae; Diosgenin; DNA Damage; Drug Antagonism; Lipid Peroxidation; Male; Mesocricetus; Micronuclei, Chromosome-Defective; Micronucleus Tests; Mutagens | 2013 |